Publications

460 publications

Enter search criteria

Keyword

Fill in keyword(s) to narrow your search.

Period

Last 7 days Last 30 days Last 365 days Specific period

Period from

The start date was not recognised. Please enter the date in the following format: DD-MM-YYYY.

Period up to

The end date was not recognised. Please enter the date in the following format: DD-MM-YYYY.

The end date may not occur before the start date.

Type

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by:

Date
Relevance

GVS assessment of Bevespi® aerosphere for the treatment of COPD

The National Health Care Institute has completed its assessment whether Bevespi® aerosphere for the treatment of COPD, can be ...

Report | 27-01-2020
GVS assessment of racecadotril (Hidrasec®) for the treatment of acute diarrhoea in infants (over 3 months of age) and children

The National Health Care Institute has completed its assessment whether racecadotril (Hidrasec®) is interchangeable with another ...

Report | 17-12-2019
GVS assessment of a 4 component meningococcal B vaccine (Bexsero®)

The National Health Care Institute has completed its assessment whether the product 4 component meningococcal B vaccine (4CMenB) ...

Report | 16-12-2019
GVS assessment of hydrocortisone (Alkindi®) for the treatment of adrenal insufficiency

The National Health Care Institute has completed its assessment whether hydrocortisone (Alkindi®) can be included in the ...

Report | 10-12-2019
Metreleptin (Myalepta®) for treatment of lipodystrophy

Zorginstituut Nederland has completed its assessment whether metreleptin (Myalepta®) for treatment of lipodystrophy can be ...

Report | 21-10-2019
GVS assessment of extension of further conditions for GLP-1ra

The minister for Medical Care asked Zorginstituut Nederland to extend the further conditions for the glucagon-like peptide 1 ...

Report | 26-09-2019
Ciclosporin (Ikervis®) for the treatment of severe keratitis in adult patients with the dry eye syndrome

The National Health Care Institute has completed its assessment whether ciclosporin (Ikervis®) for the treatment of severe ...

Report | 18-09-2019
Dabrafenib/trametinib (Tafinlar®/Mekinist®) for the adjuvant treatment of adult patients with stage III melanoma

The National Health Care Institute has completed its assessment of dabrafenib (Tafinlar®) in combination with trametinib ...

Report | 28-08-2019
GVS assessment of fampridine (Fampyra®) for use in a subgroup of MS patients

The National Health Care Institute has completed its assessment whether fampridine (Fampyra®) can be included in the Medication ...

Report | 06-08-2019
Doravirine/lamivudine/tenofovir disoproxil fumarate (Delstrigo®) for the treatment of adults infected with HIV-1

The National Health Care Institute has completed its assessment whether Delstrigo® (doravirine/lamivudine/tenofovir disoproxil ...

Report | 27-06-2019

Publications

460 publications

GVS assessment of Bevespi® aerosphere for the treatment of COPD

GVS assessment of racecadotril (Hidrasec®) for the treatment of acute diarrhoea in infants (over 3 months of age) and children

GVS assessment of a 4 component meningococcal B vaccine (Bexsero®)

GVS assessment of hydrocortisone (Alkindi®) for the treatment of adrenal insufficiency

Metreleptin (Myalepta®) for treatment of lipodystrophy

GVS assessment of extension of further conditions for GLP-1ra

Ciclosporin (Ikervis®) for the treatment of severe keratitis in adult patients with the dry eye syndrome

Dabrafenib/trametinib (Tafinlar®/Mekinist®) for the adjuvant treatment of adult patients with stage III melanoma

GVS assessment of fampridine (Fampyra®) for use in a subgroup of MS patients

Doravirine/lamivudine/tenofovir disoproxil fumarate (Delstrigo®) for the treatment of adults infected with HIV-1

Go to